Botanical species · safety record

Cinchona pubescens

The EFSA Compendium of Botanicals holds 12 constituent measurements and 1 adverse-effect record for Cinchona pubescens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cinchona pubescens Vahl

12Constituent measurements
1Safety records
3Cited sources
20Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 20 licensed products naming Cinchona pubescens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Bark
  • Dried bark
  • Dried bark (various Cinchona spp.)
  • Dried bark from trunk
  • Dried bark from twigs
  • Dried bark of young trunks and older twigs
  • Root
  • Stem bark

What the records describe

Constituents measured

  • Cinchonidine3
  • Cinchonine3
  • Quinidine3
  • Quinine3

Plant parts

  • Aerial part of plants4
  • Bark4
  • Roots and other underground parts4

Preparations

  • Solvent extraction13

Target tissues

  • Heart1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CinchonidineBarkSolvent extraction22 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
CinchonineBarkSolvent extraction37 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
QuinidineBarkSolvent extraction2.9 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
QuinineBarkSolvent extraction15 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
CinchonidineRoots and other underground partsSolvent extraction0.1 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
CinchonidineAerial part of plantsSolvent extraction0.06 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
CinchonineAerial part of plantsSolvent extraction0.1 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
CinchonineRoots and other underground partsSolvent extraction0.27 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
QuinidineRoots and other underground partsSolvent extraction0.05 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
QuinidineAerial part of plantsSolvent extraction0.01 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
QuinineRoots and other underground partsSolvent extraction0.13 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
QuinineAerial part of plantsSolvent extraction0.07 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Not statedHeartSolvent extractionHuman (as organism)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Fabiano-Tixier, Anne-Sylvie., Elomri, Abdelhakim., Blanckaert, Axelle., Seguin, Elisabeth., Petitcolas, Emmanuel., Chemat, Farid. Rapid and Green Analytical Method for the Determination of Quinoline Alkaloids from Cinchona succirubra Based on Microwave-Integrated Extraction and Leaching (MIEL) Prior to High Performance Liquid Chromatography . International journal of molecular sciences, 2011, vol. 12, no. 11, p. 7846-7860. DOI
  2. Staba, E. John., Chung, Alex C. Quinine and quinidine production by cinchona leaf, root and unorganized cultures. Phytochemistry (elsevier), 1981, vol. 20, no. 11, p. 2495-8.
  3. Durasnel, P., Vanhuffel, L., Blonde, R., Lion, F., Galas, T., Mousset-Hovaere, M., Balay, I., Viscardi, G., Valyi, L. Severe poisoning by plants used for traditional medicine in Mayotte .. Bulletin de la societe de pathologie exotique (1990), 2014, vol. 107, no. 5, p. 306-11. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue